Literature DB >> 8231211

Correction of total anomalous pulmonary venous connection in infancy.

F M Lupinetti1, T J Kulik, R H Beekman, D C Crowley, E L Bove.   

Abstract

From January 1985 through January 1993, 41 patients less than 1 year of age underwent operative correction of isolated total anomalous pulmonary venous connection. There were 24 boys and 17 girls. The median age at operation was 13 days (range 1 to 282 days) and weight was 3.6 kg (2.5 to 5.2 kg). Locations of the connections were supracardiac in 19, cardiac in 9, infracardiac in 11, and mixed supracardiac and cardiac in 2. Obstruction of the pulmonary veins was severe in 24, mild in 3, and absent in 14. Preoperative stabilization included mechanical ventilation for 15 patients for a mean duration of 2 1/2 days and extracorporeal membrane oxygenation for 1 patient for 1 day. All operations were performed with deep hypothermia and circulatory arrest (mean arrest time 34 minutes). Supracardiac connections were repaired by performing a side-to-side anastomosis between the pulmonary venous confluence and the dome of the left atrium through a superior approach between the superior vena cava and the aorta. Coronary sinus connections were repaired by enlarging the atrial septal defect and the coronary sinus communication with the left atrium and closing the atrial defect with a large patch. Infracardiac repairs included elevation and rotation of the heart to the right and an elongated side-to-side anastomosis between the common venous confluence and the left atrium. One patient died 1 week postoperatively of persistent pulmonary hypertension. Another patient, who was supported by extracorporeal membrane oxygenation before the operation, died 3 months after the operation as a consequence of pulmonary lymphangiectasia. All other patients are alive and well with a mean follow-up of 26 months (range 3 to 77 months). One patient required two subsequent reoperations for persistent pulmonary venous obstruction, and another patient had superior vena cava obstruction necessitating reoperation. Operative treatment of total anomalous pulmonary venous connection in infants can be performed with low mortality and an infrequent need for reoperations.

Entities:  

Mesh:

Year:  1993        PMID: 8231211

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

Review 1.  Mechanical cardiopulmonary support in children and young adults: extracorporeal membrane oxygenation, ventricular assist devices, and long-term support devices.

Authors:  A C Chang; E D McKenzie
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

2.  Perioperative mechanical circulatory support in children with critical heart disease.

Authors:  Paul A Checchia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

3.  Unobstructive total anomalous pulmonary venous return: impact of early elective repair on the need for prolonged mechanical ventilatory support.

Authors:  Peter C Frommelt; David C Sheridan; Sara Deatsman; Ke Yan; Pippa Simpson; Michele A Frommelt; S Bert Litwin; James S Tweddell
Journal:  Pediatr Cardiol       Date:  2010-09-17       Impact factor: 1.655

4.  [Surgical treatment of total anomalous pulmonary venous connection--clinical aspects of pulmonary venous obstruction].

Authors:  K Yoshihara; T Ozawa; H Sakuragawa; T Fujii; N Shiono; Y Watanabe; N Koyama; H Matsuura; T Saji; Y Takanashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-11

5.  Early- and intermediate-term results of surgical correction in 122 patients with total anomalous pulmonary venous connection and biventricular physiology.

Authors:  Keyan Zhao; Huishan Wang; Zengwei Wang; Hongyu Zhu; Minhua Fang; Xianyang Zhu; Nanbin Zhang; Hengchang Song
Journal:  J Cardiothorac Surg       Date:  2015-11-24       Impact factor: 1.637

6.  Computed tomography findings and preoperative risk factors for mortality of total anomalous pulmonary venous connection.

Authors:  Yonghua Xiang; Guanxun Cheng; Ke Jin; Xuehua Zhang; Yuan Yang
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-25       Impact factor: 2.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.